-
·
Understanding MPN Biomarkers: JAK2, CALR, MPL & More
Andrew Schorr (MPN patient advocate) sits down with Dr. Angela Fleischman (University of California, Irvine) to unpack what JAK2, CALR, and MPL mean for MPN diagnosis and everyday care. They also explain how added findings (ASXL1, IDH1/2, EZH2), next-generation sequencing (NGS), and risk scores can inform treatment choices and clinical trials.
-
·
Inside Your Scans: How CT, PET/CT, MRI and Ultrasound Guide Blood Cancer Care
Inside Your Scans brings clear, patient-friendly answers about CT, PET/CT, MRI, and ultrasound in blood cancer care. Experts Dr. Robyn Stacy Humphries (Charlotte Radiology) and Dr. David Prologo (Winship Cancer Institute of Emory University) explain imaging basics, biopsies, ports vs. central lines, ways to ease scan anxiety, and how radiologists and oncologists work together.
-
·
Building a CLL Game Plan: Strategies for Treatment, Trials, and Team Building
CLL Patient advocate Jeff Folloder and expert hematologist-oncologist Dr. Nicole Lamanna (Columbia University Irving Medical Center) explain how today’s innovative targeted therapies, time-limited treatment options, and emerging clinical trials can help patients craft a care strategy that truly fits their needs.
-
·
A New Era in Ovarian Cancer Treatment and Platinum-Resistant Options
Learn about the latest therapies, clinical trials, and biomarker tests for platinum-resistant ovarian cancer from expert Dr. Kathleen Moore.
-
·
Your Follicular Lymphoma Questions, Answered by Dr. Peter Martin
Got questions about follicular lymphoma? Dr. Peter Martin answers what matters most to patients in this expert Q&A. Register now to join.
-
·
Looking to the Future: Treatment Paths for Relapsed/Refractory DLBCL
Hear Dr. Joshua Brody and Dr. Amir Steinberg discuss new treatments for relapsed/refractory DLBCL and how academic–community collaboration helps patients access the best care. Moderated by survivor Stephanie Chuang.
-
·
Advanced Endometrial Cancer: Making Informed Treatment Decisions and Accessing Clinical Trials
Advanced endometrial cancer is not one-size-fits-all. In this free educational program, expert Dr. Brian Slomovitz joins The Patient Story to explain how biomarker testing, new therapies, and clinical trials are giving patients more options than ever before.
-
·
MPN Lab Results: Feel More Confident Reading Your Labs
Join Dr. Aaron Gerds of Cleveland Clinic and longtime MPN patient advocate Ruth Fein Revell as they explore how mutation testing—including JAK2, CALR, and MPL—can shape care, what trends to watch in your lab results, and how to have more confident conversations with your doctor.
-
·
Waldenström’s: What IgM and Other Lab Markers Tell Us
Dr. Stephen Ansell of Mayo Clinic breaks down how lab results like IgM, genetic mutations, and CBC results inform diagnosis, treatment timing, and monitoring in Waldenstrom. Patient advocate Annmarie Seldon shares her own story and what she wishes she’d known earlier.
-
·
CLL Lab Tests Revealed: Navigating Care with Confidence
In this discussion, Dr. Adam Kittai and CLL patient advocate Michele Nadeem-Baker explain how common tests—like CBC, IGHV, and MRD—help guide diagnosis, prognosis, and when it’s time to start treatment.
